Treatment of posttraumatic osteomyelitis with oral linezolid;Tratamiento con linezolid oral en osteomielitis postraumáticas

Revista de Ortopedia y Traumatologia

Volumn 51, Issue 2, 2007, Pages 75-79

  Romero Candau, F J ^a   Perez Ferri R ^a   Madrigals, J M ^a   Najarro, F ^a   Santosy, F ^a   Huesa, F ^a  

^a Hospital FREMAP   (Spain)

Author keywords

Linezolid; Methicillin resistant staphylococcus; Posttraumatic osteomyelitis

Indexed keywords

EID: 34247391839     PISSN: 04825985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0482-5985(07)74571-6     Document Type: Article

References (17)

1. Fernández-Yruegas D. Tratamiento de la osteomielitis crónica. Rev Ortop Traumatol. 2004;48:4-11.
2. Klemm KW. Treatment of infected pseudoarthrosis of the femur and tibia with interlocking nail. Clin Orthop. 1986;212:174-84.
3. Cierny G. III Infected Tibial Nonunions. Clin Orthop. 1999;360:97-105.
4. Mader JT, Wang J, Calhoun JH. Antibiotic therapy for musculoskeletal infections. J Bone Joint Surg Am. 2001 ;83:187890.
5. Champney WS, Miller M. Linezolid is an especific inhibitor of 50S ribosomal subunit formation in Staphylococcus aureus cells. Curri Microbiol. 2002;44:350-6.
6. Slatter JG, Stalker DJ, Feenstra KL, Welshman IR, Bruss JB, Sams JP, et al. Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of linezolid to healthy human subjects. Drug Metab Dispos. 2001 ;29:1136-45.
7. Lovering AM, Zhang J, Bannister GC, Lankester BJA, Brown JHM, Narendra G, et al. Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. J Antimicrob Chemother. 2002;50:73-7.
8. Rana B, Butcher I, Grigoris P, Murnaghan C, Seaton RA, Tobin CM. Linezolid penetration into osteo-articular tissues. J Antimicrob Chemother. 2002;50:747-50.
9. Kutscha-Lissberg F, Hebler U, Muhr G, Köller M. Linezolid penetration into bone and joint tissues infected with methicillin-resistant staphylococci. Antimicrobial Agents Chemother. 2003;47:3964-6.
10. Chien JW, Kucia ML, Salata RA. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections. Clin Infect Dis. 2000;30:146-51.
11. Rubinstein E, Cammarata S, Oliphant T, Wunderink R. Linezolid Nosocomial Pneumonia Study Group. Linezolid versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized; doble-blind, multicenter study. Clin Infect Dis. 2001;32:402-12.
12. Melzer M, Goldsmith D, Gransden W. Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteriemias. Clin Infect Dis. 2000;31:208-9.
13. Till M, Wixson RL, Pertel PE. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis. 2002;34:1412-4.
14. Rayner CR, Baddour LM, Birminghan MC, Norden C, Meagher AK, Schentag JJ. Linezolid in the treatment of osteomyelitis: results of compassionate use experience. Infection. 2004;32:8-14.
15. Rao N, Ziran BH, Hall RA, Santa ER. Successful treatment of chronic bone and joint infections with oral linezolid. Clin Orthop. 2004;427:67-71.
16. Razonable RR, Osmon DR, Steckelberg JM. Linezolid Therapy for Orthopedic Infections. Mayo Clin Proc. 2004;79: 1137-44.
17. Bassetti M, Vitale F, Melica G, Righi E, Di Biagio A, Molfetta L, et al. Linezolid in the treatment of Gram-positive prosthetic joint infections. J Antimicrob Chemother. 2005; 55:387-90.